Rocket Lab Reports Record Q4 2025 Revenue, Delays Neutron Launch to Q4 2026

RKLB
March 02, 2026

Rocket Lab reported record quarterly revenue of $180 million for fiscal 2025, a 38% year‑over‑year increase that was driven by strong demand across its commercial and government contracts. The company also posted a record annual revenue of $602 million and a backlog of $1.85 billion, up 73% from the prior year, underscoring robust order flow. GAAP earnings per share for the quarter were a loss of $0.09, in line with analyst expectations of a small negative figure.

For the first quarter of fiscal 2026, Rocket Lab guided revenue to $185 million to $200 million, a range that falls short of the consensus estimate of $199 million. The company also projected GAAP gross margin to be between 34% and 36%, down from the 38% margin reported in Q4 2025. Management cited a shift toward lower‑margin space‑systems revenue and ongoing investment in the Neutron launch vehicle as the primary drivers of the margin compression and the more conservative revenue outlook.

The delay of the Neutron rocket’s inaugural flight to the fourth quarter of fiscal 2026 follows a third‑party manufacturing defect that caused a rupture in a Stage 1 tank during January 2026 testing. The incident has pushed the launch window back, delaying the company’s entry into the medium‑lift market and extending the period of capital intensity without the expected revenue upside. The postponement also raises concerns about Rocket Lab’s ability to capture market share before competitors such as Blue Origin and Firefly Aerospace scale their own medium‑lift offerings.

On February 27 2026, Rocket Lab successfully completed its seventh HASTE flight, deploying a DART AE scramjet for the U.S. Department of War’s Defense Innovation Unit. The flight demonstrates progress in the company’s hypersonic test program, a separate initiative that supports national security priorities and showcases Rocket Lab’s broader technological capabilities.

CEO Sir Peter Beck said the tank failure was unexpected and that the vehicle had met its anticipated flight loads before the rupture. He emphasized the company’s focus on reliability, stating, “Success is reaching orbit.” CFO Adam Spice noted that the company anticipates a slight step down in both GAAP and non‑GAAP gross margins for the first quarter, attributing the compression to a greater mix of space‑systems versus higher‑margin launch services and a weaker margin mix within the space‑systems segment.

Investor sentiment following the earnings release was mixed. While the company beat revenue expectations and posted a record backlog, the delayed Neutron launch and lower‑than‑expected guidance for the next quarter tempered enthusiasm, leading to a cautious market reaction.

The Neutron delay and margin compression signal headwinds for Rocket Lab’s growth trajectory. The postponement extends the period of capital expenditure without the anticipated revenue from the new launch vehicle, potentially impacting valuation. The shift toward lower‑margin space‑systems revenue and the need to invest heavily in Neutron development also suggest that the company is prioritizing long‑term capability building over short‑term profitability.

Segment analysis shows that Rocket Lab’s Space Systems division has become a larger contributor to revenue than its Launch Services division, reflecting a strategic shift toward higher‑volume, lower‑margin contracts. This mix shift is a key factor behind the margin compression and the guidance for the upcoming quarter.

Overall, Rocket Lab’s Q4 2025 results demonstrate strong demand and a healthy backlog, but the delayed Neutron launch and cautious outlook for Q1 2026 highlight the challenges of scaling new technology while managing cost pressures and competitive dynamics.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.